Alphina Therapeutics
PrivateLast Round
Seed Round
Mar 16, 2026
Total Funding Raised
$40M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Alphina Therapeutics is a biotechnology company developing small molecule inhibitors of NAMPT to treat a variety of solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Alphina Therapeutics Comparables
Compare Alphina Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Remedy Plan Therapeutics | 87% | |
| OncoTartis, Inc. | 81% | |
| Tessellate BIO | 76% |
Alphina Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Mar 16, 2026 | ||||
| Series A | Sep 1, 2021 | ||||
| Pre Seed | Dec 15, 2020 |
Key People
Founding team and executive leadership
Alphina Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Connecticut Innovations | Series A, Pre Seed |
| HighCape Capital | Series A, Pre Seed |
| Osage University Partners | Series A |
| Canaan Partners | Series A |
| Alexandria Venture Investments | Series A |
| Alexandria Venture Investments | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 15, 2026
Monthly visitors increased 48% month-over-month.
Alphina Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Alphina Therapeutics's valuation, stock price, and market status.
Is Alphina Therapeutics a public or private company?
Alphina Therapeutics is a private company.
What is the current stock price of Alphina Therapeutics?
Alphina Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Alphina Therapeutics worth (valuation)?
Valuation information for Alphina Therapeutics is not publicly available.
Can I buy Alphina Therapeutics stock?
Alphina Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Alphina Therapeutics's last funding round?
Alphina Therapeutics's most recent funding round was Seed Round on March 16, 2026.
Who are the main investors in Alphina Therapeutics?
Key investors in Alphina Therapeutics include Canaan Partners.
Will Alphina Therapeutics IPO soon?
No public IPO plans have been announced for Alphina Therapeutics.
How can I track Alphina Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Alphina Therapeutics's secondary market activity and sign up for updates.